ENDRA amends ASPI merger; Renergen loan capacity to rise to $200M, min cash set at $3.8M

ENDRA Life Sciences Inc.

First Amendment dated Oct 1, 2026 to the June 25, 2026 deal under which Kruger Merger Sub (ENDRA) merges into Noble Africa LLC, surviving as a wholly-owned ENDRA subsidiary.
Minimum cash closing condition now $3,800,002.59, reduced by cumulative IRA Payments under ENDRA's July 15, 2026 investor relations agreement with RedChip Companies.
Renergen's borrowing capacity from ASPI rises from $80M to up to $120M via a fifth addendum to the May 19, 2025 term loan, and to up to $200M via a sixth addendum due at or before closing.
ENDRA and LHE LNG Holdings amended the May 27, 2026 warrants to remove the 4.99% beneficial ownership cap; they cover 511,541 pre-funded shares at $0.0001 and 1,156,774 shares at $6.57.
Classified board dropped: the post-closing ENDRA board will include the Company CEO, at least five non-executive directors designated by ASPI/Noble, and one ENDRA-designated director.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.